vs
Side-by-side financial comparison of ENTEGRIS INC (ENTG) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $823.9M, roughly 1.7× ENTEGRIS INC). ENTEGRIS INC runs the higher net margin — 6.0% vs 4.5%, a 1.5% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (5.0% vs -3.1%). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (5.3% CAGR vs 3.4%).
Entegris, Inc. is a supplier of materials for the semiconductor and other high-tech industries. Entegris has approximately 8,000 employees throughout its global operations. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. The company’s corporate headquarters are in Billerica, Massachusetts.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
ENTG vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $823.9M | $1.4B |
| Net Profit | $49.4M | $63.8M |
| Gross Margin | 43.8% | — |
| Operating Margin | 12.7% | 6.9% |
| Net Margin | 6.0% | 4.5% |
| Revenue YoY | -3.1% | 5.0% |
| Net Profit YoY | -51.7% | -14.7% |
| EPS (diluted) | $0.33 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.4B | ||
| Q4 25 | $823.9M | $1.4B | ||
| Q3 25 | $807.1M | $1.4B | ||
| Q2 25 | $792.4M | $1.3B | ||
| Q1 25 | $773.2M | $1.4B | ||
| Q4 24 | $849.8M | $1.3B | ||
| Q3 24 | $807.7M | $1.3B | ||
| Q2 24 | $812.7M | $1.3B |
| Q1 26 | — | $63.8M | ||
| Q4 25 | $49.4M | $20.2M | ||
| Q3 25 | $70.5M | $28.8M | ||
| Q2 25 | $52.8M | $40.6M | ||
| Q1 25 | $62.9M | $56.7M | ||
| Q4 24 | $102.2M | $-16.1M | ||
| Q3 24 | $77.6M | $55.6M | ||
| Q2 24 | $67.7M | $77.6M |
| Q1 26 | — | — | ||
| Q4 25 | 43.8% | — | ||
| Q3 25 | 43.5% | — | ||
| Q2 25 | 44.4% | — | ||
| Q1 25 | 46.1% | — | ||
| Q4 24 | 45.6% | — | ||
| Q3 24 | 46.0% | — | ||
| Q2 24 | 46.2% | — |
| Q1 26 | — | 6.9% | ||
| Q4 25 | 12.7% | 4.6% | ||
| Q3 25 | 15.2% | 5.4% | ||
| Q2 25 | 13.4% | 6.5% | ||
| Q1 25 | 15.8% | 8.3% | ||
| Q4 24 | 17.6% | 1.6% | ||
| Q3 24 | 16.9% | 4.3% | ||
| Q2 24 | 16.0% | 5.8% |
| Q1 26 | — | 4.5% | ||
| Q4 25 | 6.0% | 1.4% | ||
| Q3 25 | 8.7% | 2.1% | ||
| Q2 25 | 6.7% | 3.0% | ||
| Q1 25 | 8.1% | 4.2% | ||
| Q4 24 | 12.0% | -1.2% | ||
| Q3 24 | 9.6% | 4.4% | ||
| Q2 24 | 8.3% | 6.1% |
| Q1 26 | — | $0.35 | ||
| Q4 25 | $0.33 | $0.17 | ||
| Q3 25 | $0.46 | $0.23 | ||
| Q2 25 | $0.35 | $0.32 | ||
| Q1 25 | $0.41 | $0.44 | ||
| Q4 24 | $0.67 | $-0.12 | ||
| Q3 24 | $0.51 | $0.43 | ||
| Q2 24 | $0.45 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $360.4M | $25.7M |
| Total DebtLower is stronger | $3.7B | $1.8B |
| Stockholders' EquityBook value | $4.0B | $2.1B |
| Total Assets | $8.4B | $6.0B |
| Debt / EquityLower = less leverage | 0.94× | 0.88× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $25.7M | ||
| Q4 25 | $360.4M | $26.5M | ||
| Q3 25 | $399.8M | $60.1M | ||
| Q2 25 | $376.8M | $52.3M | ||
| Q1 25 | $340.9M | $53.2M | ||
| Q4 24 | $329.2M | $59.7M | ||
| Q3 24 | $432.1M | $191.5M | ||
| Q2 24 | $320.0M | $111.2M |
| Q1 26 | — | $1.8B | ||
| Q4 25 | $3.7B | $1.8B | ||
| Q3 25 | $3.8B | $1.7B | ||
| Q2 25 | $4.0B | $1.8B | ||
| Q1 25 | $4.0B | $1.8B | ||
| Q4 24 | $4.0B | $1.7B | ||
| Q3 24 | $4.1B | $3.1B | ||
| Q2 24 | $4.1B | $3.6B |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $4.0B | $1.7B | ||
| Q3 25 | $3.9B | $1.7B | ||
| Q2 25 | $3.8B | $1.7B | ||
| Q1 25 | $3.7B | $1.7B | ||
| Q4 24 | $3.7B | $1.7B | ||
| Q3 24 | $3.6B | $1.9B | ||
| Q2 24 | $3.5B | $1.4B |
| Q1 26 | — | $6.0B | ||
| Q4 25 | $8.4B | $5.9B | ||
| Q3 25 | $8.4B | $5.7B | ||
| Q2 25 | $8.4B | $5.7B | ||
| Q1 25 | $8.4B | $5.7B | ||
| Q4 24 | $8.4B | $5.6B | ||
| Q3 24 | $8.5B | $8.0B | ||
| Q2 24 | $8.3B | $7.9B |
| Q1 26 | — | 0.88× | ||
| Q4 25 | 0.94× | 1.06× | ||
| Q3 25 | 0.99× | 1.03× | ||
| Q2 25 | 1.05× | 1.10× | ||
| Q1 25 | 1.06× | 1.03× | ||
| Q4 24 | 1.08× | 1.01× | ||
| Q3 24 | 1.15× | 1.62× | ||
| Q2 24 | 1.18× | 2.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $192.0M | — |
| Free Cash FlowOCF − Capex | $134.0M | — |
| FCF MarginFCF / Revenue | 16.3% | — |
| Capex IntensityCapex / Revenue | 7.0% | — |
| Cash ConversionOCF / Net Profit | 3.89× | — |
| TTM Free Cash FlowTrailing 4 quarters | $396.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $192.0M | $64.3M | ||
| Q3 25 | $249.5M | $175.3M | ||
| Q2 25 | $113.5M | $110.3M | ||
| Q1 25 | $140.4M | $-3.5M | ||
| Q4 24 | $176.1M | $125.4M | ||
| Q3 24 | $197.2M | $181.0M | ||
| Q2 24 | $111.2M | $278.2M |
| Q1 26 | — | — | ||
| Q4 25 | $134.0M | $5.2M | ||
| Q3 25 | $182.8M | $122.2M | ||
| Q2 25 | $47.0M | $45.6M | ||
| Q1 25 | $32.4M | $-55.8M | ||
| Q4 24 | $68.6M | $62.0M | ||
| Q3 24 | $115.0M | $130.3M | ||
| Q2 24 | $51.9M | $222.6M |
| Q1 26 | — | — | ||
| Q4 25 | 16.3% | 0.4% | ||
| Q3 25 | 22.6% | 9.0% | ||
| Q2 25 | 5.9% | 3.4% | ||
| Q1 25 | 4.2% | -4.1% | ||
| Q4 24 | 8.1% | 4.7% | ||
| Q3 24 | 14.2% | 10.2% | ||
| Q2 24 | 6.4% | 17.4% |
| Q1 26 | — | — | ||
| Q4 25 | 7.0% | 4.2% | ||
| Q3 25 | 8.3% | 3.9% | ||
| Q2 25 | 8.4% | 4.8% | ||
| Q1 25 | 14.0% | 3.9% | ||
| Q4 24 | 12.7% | 4.8% | ||
| Q3 24 | 10.2% | 4.0% | ||
| Q2 24 | 7.3% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.89× | 3.19× | ||
| Q3 25 | 3.54× | 6.09× | ||
| Q2 25 | 2.15× | 2.72× | ||
| Q1 25 | 2.23× | -0.06× | ||
| Q4 24 | 1.72× | — | ||
| Q3 24 | 2.54× | 3.25× | ||
| Q2 24 | 1.64× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENTG
| Fabs | $516.3M | 63% |
| Equipment And Engineering | $121.8M | 15% |
| Chemical And Materials | $83.8M | 10% |
| Other | $61.7M | 7% |
| Non Semi | $40.3M | 5% |
SEM
Segment breakdown not available.
